It is well established that the brain is capable of consuming ketone bodies, especially during low glucose availability, e.g. fasting. Cerebral metabolism of ketone bodies depends on passage of the blood brain barrier and especially the global blood concentration of ketone bodies. Ketone bodies can be administered exogenously, and the most commonly used in clinical trials is 3-hydroxybutyrate (3-OHB). 3-OHB is carried by simple diffusion and facilitated diffusion through several monocarboxylic acid transporters (MCTs) across the blood-brain barrier. To our knowledge, no studies in human adults exist that concurrently measure 3-OHB concentrations in blood and cerebrospinal fluid (CSF) after ingestion or infusion of exogenous ketone supplementation, necessitating further study. Aims: * The 3-OHB CSF/blood ratio after oral ingestion of 30 g ketone ester - primary endpoint * The window of effect: Ketone supplementation 1 h or 2 h before CSF sampling * If concentration measurements by point-of-care testing are non-inferior to mass spectrometry * If acute 3-OHB ingestion increases plasma brain-derived neurotrophic factor (BDNF) levels
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Enrollment
24
Commercially available ketone ester drink (KetoneAid, Virginia, USA)
Taste and appearance matched noncaloric placebo drink
Aarhus University Hospital
Aarhus, Denmark
3-OHB CSF/blood ratio
After oral ingestion of 30 g ketone ester drink or placebo drink
Time frame: 1-2 hours after ingestion
CSF 3-OHB concentrations, POCT
After oral ingestion of 30 g ketone ester drink or placebo drink, Point-of-care testing (POCT)
Time frame: 1-2 hours after ingestion
CSF 3-OHB concentrations, Mass Spectrometry
After oral ingestion of 30 g ketone ester drink or placebo drink, Mass Spectrometry Detection
Time frame: 1-2 hours after ingestion
CSF glucose concentrations
After oral ingestion of 30 g ketone ester drink or placebo drink
Time frame: 1-2 hours after ingestion
Blood 3-OHB concentrations
After oral ingestion of 30 g ketone ester drink or placebo drink, Point-of-care testing (POCT)
Time frame: 1-2 hours after ingestion
Plasma 3-OHB concentrations
After oral ingestion of 30 g ketone ester drink or placebo drink, Mass Spectrometry Detection
Time frame: 1-2 hours after ingestion
Blood glucose concentrations
After oral ingestion of 30 g ketone ester drink or placebo drink, Point-of-care testing (POCT)
Time frame: 1-2 hours after ingestion
Plasma BDNF concentrations
After oral ingestion of 30 g ketone ester drink or placebo drink
Time frame: 1-2 hours after ingestion
Blood 3-OHB concentrations
Before oral ingestion of 30 g ketone ester drink or placebo drink, Point-of-care testing (POCT)
Time frame: Before ingestion
Plasma 3-OHB concentrations
After oral ingestion of 30 g ketone ester drink or placebo drink, Mass Spectrometry Detection
Time frame: Before ingestion
Blood glucose concentrations
Before oral ingestion of 30 g ketone ester drink or placebo drink, Point-of-care testing (POCT)
Time frame: Before ingestion
Plasma BDNF concentrations
Before oral ingestion of 30 g ketone ester drink or placebo drink
Time frame: Before ingestion
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.